Browsing by Author Daskalopoulou, S. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 4 to 12 of 12 < previous 
TitleAuthor(s)Issue date???itemlist.???
Fenofibrate and losartanDaskalopoulou, S. S.; Mikhailidis, D. P.; Athyros, V. G.; Papageorgiou, A. A.; Elisaf, M. S.24-Nov-2015-
Fenofibrate: metabolic and pleiotropic effectsTsimihodimos, V.; Miltiadous, G.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
The impact of serum uric acid on cardiovascular outcomes in the LIFE studyDaskalopoulou, S. S.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D.24-Nov-2015-
Management of high triglycerides: what non-specialists in lipids need to knowLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.24-Nov-2015-
The predictive value of lipid markers in vascular diseaseMilionis, H. J.; Daskalopoulou, S. S.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre StudyAthyros, V. G.; Mikhailidis, D. P.; Papageorgiou, A. A.; Didangelos, T. P.; Ganotakis, E. S.; Symeonidis, A. N.; Daskalopoulou, S. S.; Kakafika, A. I.; Elisaf, M. S.24-Nov-2015-
Prevention and treatment of the metabolic syndromeDaskalopoulou, S. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
A review of the lipid-related effects of fluvastatinLiberopoulos, E. N.; Daskalopoulou, S. S.; Mikhailidis, D. P.; Wierzbicki, A. S.; Elisaf, M. S.24-Nov-2015-
Uric acid levels and vascular diseaseDaskalopoulou, S. S.; Athyros, V. G.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-